Alteplase for Stroke

{
  "resourceType" : "EvidenceVariable",
  "id" : "example-alteplase-for-stroke",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n      \n      <p>\n        &quot;Alteplase for Stroke&quot; is an exposure concept with a detailed dosing instruction that may be used in expressing what an Evidence is about.\n      </p>\n\t\n    </div>"
  },
  "contained" : [{
    "resourceType" : "Group",
    "id" : "Definition-Group",
    "title" : "VariableDefinition: Alteplase for Stroke",
    "membership" : "conceptual",
    "characteristic" : [{
      "code" : {
        "text" : "Defined by Reference"
      },
      "valueUri" : "http://example.org/fhir/ActivityDefinition/example-alteplase-dosing",
      "exclude" : false,
      "description" : "IV alteplase 0.9 mg/kg (maximum 90 mg) as 10% of dose over 1 minute and 90% over 1 hour"
    }]
  }],
  "extension" : [{
    "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
    "valueCode" : "cds"
  }],
  "name" : "AlteplaseForStroke",
  "title" : "Alteplase for Stroke",
  "status" : "draft",
  "publisher" : "HL7 International / Clinical Decision Support",
  "contact" : [{
    "telecom" : [{
      "system" : "url"
    }]
  }],
  "description" : "Alteplase for Stroke",
  "actual" : false,
  "definition" : {
    "reference" : {
      "reference" : "#Definition-Group"
    }
  },
  "handling" : "dichotomous"
}